NCT02986074已完成不适用
CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 4
- 主要终点
- Visual Analog Scale (VAS) for Back Pain at SCS Trial
研究概览
简要总结
The study will compare therapeutic efficacy of a novel spinal cord stimulation leads implant based on anatomical landmarks with standard surgical implantation technique.
详细描述
The primary purpose of this study is to compare the therapeutic efficacy of the conventional, paresthesia mapping-based burst spinal cord stimulation (SCS) implantation strategy to a more novel, anatomic midline-based approach that has the potential to streamline the workflow associated with the SCS treatment continuum.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject is able to provide informed consent to participate in the study;
- •Subject is 18 years of age or older;
- •Subject has failed to respond to at least 6 months of conventional treatment including pharmacological treatment, physical therapy, epidural injections and/or radiofrequency therapy as per NICE Tag 0159;
- •FBSS subjects with predominant low back pain;
- •Subject has a lower back pain intensity of at least 6.0 out of 10.0 on the VAS at baseline;
- •Subject is on stable pain medications with a total opioid equivalent of 120 mgs a day or less for at least 28 days prior to enrolling in this study, and is willing to stay on those medications with no dose adjustments until activation of the permanently implanted SCS device;
- •Subject's medical record has been evaluated by the Investigator to ensure that the subject is a good candidate for a neurostimulation system;
- •Subject is willing to cooperate with the study requirements including compliance with the regimen and completion of all office visits;
- •Female candidates of child-bearing potential agree to commit to the use of an effective method of contraception (including but not limited to sterilization, barrier devices, oral contraceptives, intrauterine devices (IUDs), condoms, rhythm method, or abstinence) for the duration of the study
排除标准
- •Subjects with significant scoliosis even if surgically corrected
- •Subject is currently participating in a clinical investigation that includes an active treatment arm;
- •Subject has been implanted with or participated in a trial period for a neurostimulation system;
- •Subject has an infusion pump;
- •Subject has evidence of an active disruptive psychological or psychiatric disorder as determined as per standard of care;
- •Subject has a current diagnosis of a coagulation disorder, bleeding diathesis, progressive peripheral vascular disease or uncontrolled diabetes mellitus;
- •Subject has a current diagnosis of a progressive neurological disease as determined by the Investigator;
- •Subject is immunocompromised;
- •Subject has an existing medical condition that is likely to require repetitive MRI evaluation in the future (i.e. epilepsy, stroke, multiple sclerosis, acoustic neuroma, tumor);
- •Subject has history of cancer requiring active treatment in the last 12 months;
- •Subject has an existing medical condition that is likely to require the use of diathermy in the future;
- •Subject has documented history of allergic response to titanium or silicone;
- •Subject has a documented history of substance abuse (narcotics, alcohol, etc.) or substance dependency in the 6 months prior to baseline data collection;
- •Female candidates of child bearing potential that are pregnant (confirmed by positive urine/blood pregnancy test).
研究组 & 干预措施
Anatomical midline lead first
Experimental
subjects in this group will receive stimulation first using an anatomical midline placed lead and subsequently using a paresthesia mapping placed lead
干预措施: Anatomical midline lead evaluation first (Device)
Paresthesia mapping lead first
Experimental
subjects in this group will receive stimulation first using a paresthesia mapping placed lead and subsequently using an anatomical midline placed lead
干预措施: Paresthesia mapping lead evaluation first (Device)
结局指标
主要结局
Visual Analog Scale (VAS) for Back Pain at SCS Trial
时间窗: after 2 weeks of SCS trial
Pain questionnaire - (Scale is 0-100 mm with 0 meaning no pain and 100 meaning worst pain imaginable)
次要结局
- Visual Analog Scale (VAS) for Back Pain at 6 Months(6 months after activation of permanent SCS implant)
- ODI at 6 Months(6 months after activation of permanent SCS implant)
- EQ-5D at SCS Trial(after 2 weeks of SCS trial)
- ODI at 3 Months(3 months after activation of permanent SCS implant)
- EQ-5D at 6 Month(6 months after activation of permanent SCS implant)
- Satisfaction Questionnaire(12 month follow up)
- Visual Analog Scale (VAS) for Back Pain at 3 Months(3 months after activation of permanent SCS implant)
- ODI at SCS Trial(first SCS trial assessment (up to two weeks after electrodes implantation))
- ODI at 12 Months(12 months after activation of permanent SCS implant)
- Visual Analog Scale (VAS) for Back Pain at 12 Months(12 months after activation of permanent SCS implant)
- EQ-5D at 3 Month(3 months after activation of permanent SCS implant)
- EQ-5D at 12 Month(12 months after activation of permanent SCS implant)
研究者
研究点 (4)
Loading locations...
相似试验
已完成
不适用
Comparison of the Effects of Two Spinal Cord Stimulation (SCS) Therapies on Subject Reported Pain (BENEFIT-02)Chronic Low Back PainChronic Leg PainNCT03594266Biotronik, Inc.136
已完成
2 期
A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic DysphagiaChronic DysphagiaMultiple SclerosisParkinson DiseaseNCT00376506National Institute of Neurological Disorders and Stroke (NINDS)10
进行中（未招募）
不适用
SPARC Bladder Mapping and Training StudySpinal Cord InjuriesNCT03452007University of Louisville10
已完成
4 期
Spinal Cord Stimulation for Low Back PainChronic PainNCT00205868Boston Scientific Corporation304
招募中
不适用
Evaluation of Neuroprosthesis with Sensory Feedback for Modulation of Phantom Limb Pain and Enhancing Quality of LifePhantom Limb PainNCT06702904Skolkovo Institute of Science and Technology50